- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Artificial Intelligence and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Amanda J. Klingler
News 3 results
Recognition
September 8, 2023
LMG Life Sciences Honors King & Spalding as its Government Investigations Firm of the Year and Non-IP Impact Case of Year – United States
Cases & Deals
December 7, 2022
King & Spalding Helps Get Thousands of Claims Dismissed in Zantac MDL
Press Release
November 3, 2016
King & Spalding Elects 14 New Partners Across Seven Offices
Events 12 results
Conference
November 7, 2023
Pharmaceutical University 2023
Conference
September 7, 2023
16th Annual King & Spalding Medical Device Summit
Speaking Engagement
September 7, 2023
King & Spalding’s Cross-Disciplinary Life Sciences Team to Present on AI at the 16th Annual Medical Device Summit
Webinar
August 29, 2023
Investigations & Enforcement Developments for Life Sciences and Healthcare Companies
Insights 11 results
Article · Source: Law360
July 6, 2023
Mitigating Risks Of Developing Drugs And Devices With AI
Client Alert
May 19, 2023
FDA Releases Guidance on Testing High-Risk Drug Components for Diethylene Glycol and Ethylene Glycol
Client Alert
January 9, 2023
Nearly a Century in the Making: Congress Modernizes FDA’s Regulation of Cosmetics
Client Alert
December 19, 2022
FDA Warns Drug & Device Firms Against Delaying & Limiting Facility Inspections in New Draft Guidance